Literature DB >> 25276995

[Pancreatic cancer in 2014: screening and epidemiology].

Laurent Bochatay, Marc Girardin, Philippe Bichard, Jean-Louis Frossard.   

Abstract

Pancreatic cancer remains today the cancer with the worst prognosis with 330300 deaths per year worldwide with a cancer prevalence of 211500 cases in 2012. Despite progress made in the understanding of the pathophysiology of this neoplasia, morbidity and mortality have not been modified. Tobacco remains the only modifiable risk factor with an impact on the incidence of pancreatic cancer. Screening programs involving medical imaging and serum markers have so far failed to alter the incidence and prognosis of the disease, even in selected populations with high risk. However, screening programs allowed some high-risk patients to be diagnosed early and therefore have been received care at an asymptomatic stage. The impact on the prognosis has nevertheless not been demonstrated yet.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25276995

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  5 in total

Review 1.  Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis.

Authors:  Yimin Zhang; Jun Yang; Hongjuan Li; Yihua Wu; Honghe Zhang; Wenhu Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.

Authors:  Sahitya K Denduluri; Olumuyiwa Idowu; Zhongliang Wang; Zhan Liao; Zhengjian Yan; Maryam K Mohammed; Jixing Ye; Qiang Wei; Jing Wang; Lianggong Zhao; Hue H Luu
Journal:  Genes Dis       Date:  2015-03-01

Review 3.  Smoking and Pancreatic Cancer: Smoking Patterns, Tobacco Type, and Dose-Response Relationship.

Authors:  Muhammad Subhan; Nisha Saji Parel; Parimi Vamsi Krishna; Anuradha Gupta; Kamsika Uthayaseelan; Kivonika Uthayaseelan; Monika Kadari
Journal:  Cureus       Date:  2022-06-16

Review 4.  Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Authors:  Wei Han; Fang Cao; Min-bin Chen; Rong-zhu Lu; Hua-bing Wang; Min Yu; Chun-tao Shi; Hou-zhong Ding
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

Review 5.  Prevention of pancreatic cancer.

Authors:  Stefan Kuroczycki-Saniutycz; Agnieszka Grzeszczuk; Zbigniew Wojciech Zwierz; Paweł Kołodziejczyk; Jakub Szczesiul; Beata Zalewska-Szajda; Krystyna Ościłowicz; Napoleon Waszkiewicz; Krzysztof Zwierz; Sławomir Dariusz Szajda
Journal:  Contemp Oncol (Pozn)       Date:  2017-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.